GENELUX CORPORATION Unrealized Gain (Loss) on Investments
GENELUX CORPORATION (GNLX) reported Unrealized Gain (Loss) on Investments of $3.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-13
- GENELUX CORPORATION unrealized gain (loss) on investments for the quarter ending 2026-06-30 was $3.00K.
- GENELUX CORPORATION unrealized gain (loss) on investments for the quarter ending 2026-03-31 was -$14.00K.
- GENELUX CORPORATION unrealized gain (loss) on investments for the quarter ending 2025-12-31 was $1.00K.
- GENELUX CORPORATION unrealized gain (loss) on investments for the quarter ending 2025-09-30 was $5.00K, a 96.30% decline year-over-year.
- GENELUX CORPORATION unrealized gain (loss) on investments for fiscal 2025 was -$55.00K, a 210.00% decline from fiscal 2024.
- GENELUX CORPORATION unrealized gain (loss) on investments for fiscal 2024 was $50.00K, a 316.67% increase from fiscal 2023.
- GENELUX CORPORATION unrealized gain (loss) on investments for fiscal 2023 was $12.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.00K 10-Q · filed 2026-08-13 | -$11.00K 10-Q · filed 2026-08-13 | -$10.00K derived: sum of 3 quarters · filed 2026-08-13 | -$5.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$14.00K 10-Q · filed 2026-05-07 | -$13.00K derived: sum of 2 quarters · filed 2026-05-07 | -$8.00K derived: sum of 3 quarters · filed 2026-05-07 | -$34.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $6.00K derived: sum of 2 quarters · filed 2026-03-19 | -$20.00K derived: sum of 3 quarters · filed 2026-08-13 | -$55.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | $5.00K 10-Q · filed 2025-11-05 | -$21.00K derived: sum of 2 quarters · filed 2026-08-13 | -$56.00K 10-Q · filed 2025-11-05 | -$116.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$26.00K 10-Q · filed 2026-08-13 | -$61.00K 10-Q · filed 2026-08-13 | -$121.00K derived: sum of 3 quarters · filed 2026-08-13 | $14.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$35.00K 10-Q · filed 2026-05-07 | -$95.00K derived: sum of 2 quarters · filed 2026-05-07 | $40.00K derived: sum of 3 quarters · filed 2026-05-07 | $34.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $75.00K derived: sum of 2 quarters · filed 2026-03-19 | $69.00K derived: sum of 3 quarters · filed 2026-03-19 | $50.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $135.00K 10-Q · filed 2025-11-05 | $129.00K derived: sum of 2 quarters · filed 2025-11-05 | $110.00K 10-Q · filed 2025-11-05 | |
| 2024-06-30 | -$6.00K 10-Q · filed 2025-08-07 | -$25.00K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$19.00K 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $12.00K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |